HODGKINS DISEASE - PROGNOSIS TREATMENT + ETIOLOGIC + IMMUNOLOGIC CONSIDERATIONS ( CONTINUED )

被引：82

作者：

AISENBERG, AC

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1964年 / 270卷 / 11期

关键词：

D O I：

10.1056/NEJM196403122701107

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：565 / &

共 38 条

[1]

ARMSTRONG JG, 1962, CANC CHEMOTHER REP, V18, P49

[2]

ATKINS HL, 1962, CANCER-AM CANCER SOC, V15, P1076, DOI 10.1002/1097-0142(196209/10)15:5<1076::AID-CNCR2820150526>3.0.CO

[3]

2-G

[4]

BOHANNON RA, 1963, CANCER RES, V23, P613

[5] CLINICAL STUDIES WITH VINCRISTINE [J].

CARBONE, PP ;

BONO, V ;

FREI, E ;

BRINDLEY, CO .

BLOOD, 1963, 21 (05) :640-&

[6] MASSIVE NITROGEN MUSTARD THERAPY IN HODGKINS DISEASE WITH PROTECTION OF BONE MARROW BY TOURNIQUETS [J].

CONRAD, ME ;

CROSBY, WH .

BLOOD, 1960, 16 (02) :1089-1103

[7]

COSTA G, 1962, CANCER CHEMOTH REP, V24, P39

[8]

DIAMOND HD, 1958, MEDICAL MANAGEMENT C

[9] CLINICAL EVALUATION OF CB-1348 IN LEUKEMIAS AND LYMPHOMAS [J].

DOAN, CA ;

WISEMAN, BK ;

BOURONCLE, BA .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) :979-995

[10] CLINICAL EXPERIENCE WITH VINCALEUKOBLASTINE IN FAR-ADVANCED HODGKINS DISEASE AND VARIOUS MALIGNANT STATES [J].

FROST, JW ;

GOLDWEIN, MI ;

BRYAN, JA .

ANNALS OF INTERNAL MEDICINE, 1962, 56 (06) :854-+

← 1 2 3 4 →